ADC Therapeutics SA (NYSE:ADCT)
Gross Margin
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides.
The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin History
Statistics
Gross Margin
1 Year | 3 Years | 5 Years | |
---|---|---|---|
Average | 77.3% | 64.4% | 64.4% |
Median | 96.3% | 96.1% | 96.1% |
Min | 0% | 0% | 0% |
Max | 97.6% | 97.6% | 97.6% |
History Chart
Gross Margin
Gross Margin Across Competitors
Gross Margin Comparison
ADC Therapeutics SA Competitors
Country | CH |
Market Cap | 596M USD |
Gross Margin |
98%
|
Country | US |
Market Cap | 268B USD |
Gross Margin |
70%
|
Country | US |
Market Cap | 130B USD |
Gross Margin |
75%
|
Country | AU |
Market Cap | 131B AUD |
Gross Margin |
55%
|
Country | US |
Market Cap | 78.1B USD |
Gross Margin |
76%
|
Country | US |
Market Cap | 70.6B USD |
Gross Margin |
88%
|
Profitability Report
View the profitability report to see the full profitability analysis for ADC Therapeutics SA.